Anupam Rasayan acquires Bliss GVS Pharma for ₹1,369 cr
pre-market1 source ↓written by the desknot a recommendation
- in Bliss GVS
- 74.2% stake
- Pharma Ltd
- ₹1,369 cr
- This includes
- 43.3% equity stake
- ₹299 per share
- for an additional
- 26%
Anupam Rasayan India Ltd has approved the acquisition of a 74.2% stake in Bliss GVS Pharma Ltd for ₹1,369 cr. This includes a 43.3% equity stake at ₹299 per share, with an open offer for an additional 26%. The deal will be financed through a ₹300 cr term loan and equity instruments.
This acquisition marks a significant move into the pharmaceutical formulations sector, potentially enhancing Anupam Rasayan's market position and product offerings.
Not investment advice. For informational purposes only.